TAT-AS1 (TAT antisense RNA 1) - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Gene: TAT-AS1 (TAT antisense RNA 1) Homo sapiens
Analyze
Symbol: TAT-AS1
Name: TAT antisense RNA 1
RGD ID: 9588085
HGNC Page HGNC:51369
Description: ASSOCIATED WITH genetic disease; Hypertyrosinemia; Microcephaly
Type: ncrna (Ensembl: lncRNA)
RefSeq Status: VALIDATED
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh381671,565,016 - 71,572,438 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl1671,564,952 - 71,578,187 (+)EnsemblGRCh38hg38GRCh38
GRCh371671,598,919 - 71,606,341 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 361670,156,386 - 70,163,842 (+)NCBINCBI36Build 36hg18NCBI36
Celera1655,915,544 - 55,922,193 (+)NCBICelera
Cytogenetic Map16q22.2NCBI
HuRef1657,366,901 - 57,374,322 (+)NCBIHuRef
CHM1_11673,011,741 - 73,019,163 (+)NCBICHM1_1
T2T-CHM13v2.01677,382,208 - 77,389,631 (+)NCBIT2T-CHM13v2.0
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations     Click to see Annotation Detail View

Phenotype Annotations     Click to see Annotation Detail View

Human Phenotype
References

References - curated
# Reference Title Reference Citation
1. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
Additional References at PubMed
PMID:16341674  


Genomics

Variants

.
Variants in TAT-AS1
240 total Variants

Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
NM_000353.3(TAT):c.668C>G (p.Ser223Ter) single nucleotide variant Tyrosinemia type II [RCV000000430] Chr16:71572224 [GRCh38]
Chr16:71606127 [GRCh37]
Chr16:16q22.2		 pathogenic
NM_000353.3(TAT):c.1249C>T (p.Arg417Ter) single nucleotide variant Tyrosinemia type II [RCV000000431] Chr16:71568260 [GRCh38]
Chr16:71602163 [GRCh37]
Chr16:16q22.2		 pathogenic
NM_000353.3(TAT):c.1085G>T (p.Gly362Val) single nucleotide variant Tyrosinemia type II [RCV000000432] Chr16:71569894 [GRCh38]
Chr16:71603797 [GRCh37]
Chr16:16q22.2		 pathogenic
GRCh38/hg38 16q22.1-24.1(chr16:70414573-84908120)x1 copy number loss See cases [RCV000133814] Chr16:70414573..84908120 [GRCh38]
Chr16:70448476..84941726 [GRCh37]
Chr16:69005977..83499227 [NCBI36]
Chr16:16q22.1-24.1		 pathogenic
GRCh38/hg38 16q21-24.1(chr16:62925929-84585795)x3 copy number gain See cases [RCV000135863] Chr16:62925929..84585795 [GRCh38]
Chr16:62959833..84619401 [GRCh37]
Chr16:61517334..83176902 [NCBI36]
Chr16:16q21-24.1		 pathogenic
GRCh38/hg38 16q22.1-24.3(chr16:70749398-90096995)x3 copy number gain See cases [RCV000137495] Chr16:70749398..90096995 [GRCh38]
Chr16:70783301..90163403 [GRCh37]
Chr16:69340802..88690904 [NCBI36]
Chr16:16q22.1-24.3		 pathogenic
GRCh38/hg38 16q21-24.3(chr16:65511483-90096995)x3 copy number gain See cases [RCV000139426] Chr16:65511483..90096995 [GRCh38]
Chr16:65545386..90163403 [GRCh37]
Chr16:64102887..88690904 [NCBI36]
Chr16:16q21-24.3		 pathogenic
GRCh38/hg38 16q22.1-23.3(chr16:69053457-83274681)x3 copy number gain See cases [RCV000142038] Chr16:69053457..83274681 [GRCh38]
Chr16:69087360..83308286 [GRCh37]
Chr16:67644861..81865787 [NCBI36]
Chr16:16q22.1-23.3		 pathogenic
GRCh38/hg38 16q21-24.3(chr16:64389378-90081985)x3 copy number gain See cases [RCV000142578] Chr16:64389378..90081985 [GRCh38]
Chr16:64423281..90148393 [GRCh37]
Chr16:62980782..88675894 [NCBI36]
Chr16:16q21-24.3		 pathogenic|likely pathogenic
GRCh38/hg38 16q12.2-24.3(chr16:52899183-90088654)x3 copy number gain See cases [RCV000143425] Chr16:52899183..90088654 [GRCh38]
Chr16:52933095..90155062 [GRCh37]
Chr16:51490596..88682563 [NCBI36]
Chr16:16q12.2-24.3		 pathogenic
GRCh38/hg38 16q21-23.3(chr16:65957829-83611443)x3 copy number gain See cases [RCV000143742] Chr16:65957829..83611443 [GRCh38]
Chr16:65991732..83645048 [GRCh37]
Chr16:64549233..82202549 [NCBI36]
Chr16:16q21-23.3		 pathogenic
GRCh38/hg38 16q21-23.1(chr16:58456122-74708723)x3 copy number gain See cases [RCV000052408] Chr16:58456122..74708723 [GRCh38]
Chr16:58490026..74742621 [GRCh37]
Chr16:57047527..73300122 [NCBI36]
Chr16:16q21-23.1		 pathogenic
GRCh38/hg38 16q21-24.3(chr16:65313395-90081985)x3 copy number gain See cases [RCV000052421] Chr16:65313395..90081985 [GRCh38]
Chr16:65347298..90148393 [GRCh37]
Chr16:63904799..88675894 [NCBI36]
Chr16:16q21-24.3		 pathogenic
GRCh38/hg38 16q22.1-24.3(chr16:70514631-90081985)x3 copy number gain See cases [RCV000052422] Chr16:70514631..90081985 [GRCh38]
Chr16:70548534..90148393 [GRCh37]
Chr16:69106035..88675894 [NCBI36]
Chr16:16q22.1-24.3		 pathogenic
GRCh38/hg38 16q22.1-23.1(chr16:68698941-74353205)x1 copy number loss See cases [RCV000053337] Chr16:68698941..74353205 [GRCh38]
Chr16:68732844..74387103 [GRCh37]
Chr16:67290345..72944604 [NCBI36]
Chr16:16q22.1-23.1		 pathogenic
GRCh38/hg38 16q22.1-23.1(chr16:69918076-76723348)x1 copy number loss See cases [RCV000053356] Chr16:69918076..76723348 [GRCh38]
Chr16:69951979..76757245 [GRCh37]
Chr16:68509480..75314746 [NCBI36]
Chr16:16q22.1-23.1		 pathogenic
GRCh38/hg38 16q22.2-22.3(chr16:71279916-73246687)x3 copy number gain See cases [RCV000053867] Chr16:71279916..73246687 [GRCh38]
Chr16:71313819..73280586 [GRCh37]
Chr16:69871320..71838087 [NCBI36]
Chr16:16q22.2-22.3		 uncertain significance
NM_000353.3(TAT):c.1047del (p.Asn349fs) deletion Tyrosinemia type II [RCV000669157] Chr16:71569932 [GRCh38]
Chr16:71603835 [GRCh37]
Chr16:16q22.2		 pathogenic|likely pathogenic
NM_000353.3(TAT):c.906_912+12del deletion Tyrosinemia type II [RCV000669658] Chr16:71570667..71570685 [GRCh38]
Chr16:71604570..71604588 [GRCh37]
Chr16:16q22.2		 likely pathogenic
NM_000353.3(TAT):c.1363T>C (p.Ter455Gln) single nucleotide variant Tyrosinemia type II [RCV000669460] Chr16:71568146 [GRCh38]
Chr16:71602049 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.1173G>A (p.Glu391=) single nucleotide variant Tyrosinemia type II [RCV000291311]|not specified [RCV000443159] Chr16:71568762 [GRCh38]
Chr16:71602665 [GRCh37]
Chr16:16q22.2		 benign|likely benign
NM_000353.3(TAT):c.*813G>C single nucleotide variant Tyrosinemia type II [RCV000276626] Chr16:71567331 [GRCh38]
Chr16:71601234 [GRCh37]
Chr16:16q22.2		 likely benign|uncertain significance
NM_000353.3(TAT):c.*581G>A single nucleotide variant Tyrosinemia type II [RCV000261381] Chr16:71567563 [GRCh38]
Chr16:71601466 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.*1056G>C single nucleotide variant Tyrosinemia type II [RCV000365564] Chr16:71567088 [GRCh38]
Chr16:71600991 [GRCh37]
Chr16:16q22.2		 likely benign|uncertain significance
NM_000353.3(TAT):c.*852G>A single nucleotide variant Tyrosinemia type II [RCV000368995] Chr16:71567292 [GRCh38]
Chr16:71601195 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.1090C>T (p.Arg364Trp) single nucleotide variant Tyrosinemia type II [RCV000348549] Chr16:71569889 [GRCh38]
Chr16:71603792 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.*1066G>A single nucleotide variant Tyrosinemia type II [RCV000307992] Chr16:71567078 [GRCh38]
Chr16:71600981 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.*1276T>A single nucleotide variant Tyrosinemia type II [RCV000400631] Chr16:71566868 [GRCh38]
Chr16:71600771 [GRCh37]
Chr16:16q22.2		 benign|likely benign
NM_000353.3(TAT):c.*774G>A single nucleotide variant Tyrosinemia type II [RCV000333966] Chr16:71567370 [GRCh38]
Chr16:71601273 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.997C>A (p.Arg333Ser) single nucleotide variant Tyrosinemia type II [RCV000352156] Chr16:71570313 [GRCh38]
Chr16:71604216 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.*81G>A single nucleotide variant Tyrosinemia type II [RCV000344926] Chr16:71568063 [GRCh38]
Chr16:71601966 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.*682T>C single nucleotide variant Tyrosinemia type II [RCV000353887] Chr16:71567462 [GRCh38]
Chr16:71601365 [GRCh37]
Chr16:16q22.2		 likely benign|uncertain significance
NM_000353.3(TAT):c.*219G>A single nucleotide variant Tyrosinemia type II [RCV000379781] Chr16:71567925 [GRCh38]
Chr16:71601828 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.*1055A>G single nucleotide variant Tyrosinemia type II [RCV000399810] Chr16:71567089 [GRCh38]
Chr16:71600992 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.1042-12C>T single nucleotide variant Tyrosinemia type II [RCV000313627] Chr16:71569949 [GRCh38]
Chr16:71603852 [GRCh37]
Chr16:16q22.2		 conflicting interpretations of pathogenicity|uncertain significance
NM_000353.3(TAT):c.*30C>A single nucleotide variant Tyrosinemia type II [RCV000383187] Chr16:71568114 [GRCh38]
Chr16:71602017 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.614T>C (p.Ile205Thr) single nucleotide variant Microcephaly [RCV001252939]|Tyrosinemia type II [RCV000313859] Chr16:71572278 [GRCh38]
Chr16:71606181 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.1046A>G (p.Asn349Ser) single nucleotide variant Tyrosinemia type II [RCV001071179] Chr16:71569933 [GRCh38]
Chr16:71603836 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.707-3C>T single nucleotide variant Tyrosinemia type II [RCV000400433] Chr16:71571661 [GRCh38]
Chr16:71605564 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.1068G>A (p.Ala356=) single nucleotide variant Tyrosinemia type II [RCV000528612] Chr16:71569911 [GRCh38]
Chr16:71603814 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.*252C>G single nucleotide variant Tyrosinemia type II [RCV000283946] Chr16:71567892 [GRCh38]
Chr16:71601795 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.*393CT[3] microsatellite Hypertyrosinemia [RCV000319211] Chr16:71567747..71567748 [GRCh38]
Chr16:71601650..71601651 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.*251T>A single nucleotide variant Tyrosinemia type II [RCV000322585] Chr16:71567893 [GRCh38]
Chr16:71601796 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.*208G>A single nucleotide variant Tyrosinemia type II [RCV000287718] Chr16:71567936 [GRCh38]
Chr16:71601839 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.*983A>G single nucleotide variant Tyrosinemia type II [RCV000311927] Chr16:71567161 [GRCh38]
Chr16:71601064 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.*350_*352del deletion Hypertyrosinemia [RCV000376258] Chr16:71567792..71567794 [GRCh38]
Chr16:71601695..71601697 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.*1276del deletion Hypertyrosinemia [RCV000343478] Chr16:71566868 [GRCh38]
Chr16:71600771 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.*713T>G single nucleotide variant Tyrosinemia type II [RCV001120346] Chr16:71567431 [GRCh38]
Chr16:71601334 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.*991T>C single nucleotide variant Tyrosinemia type II [RCV001120047] Chr16:71567153 [GRCh38]
Chr16:71601056 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.*863G>A single nucleotide variant Tyrosinemia type II [RCV001120048] Chr16:71567281 [GRCh38]
Chr16:71601184 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.709G>C (p.Ala237Pro) single nucleotide variant not specified [RCV003317735] Chr16:71571656 [GRCh38]
Chr16:71605559 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.1298G>A (p.Arg433Gln) single nucleotide variant Tyrosinemia type II [RCV000665071] Chr16:71568211 [GRCh38]
Chr16:71602114 [GRCh37]
Chr16:16q22.2		 conflicting interpretations of pathogenicity|uncertain significance
NM_000353.3(TAT):c.1125+1G>T single nucleotide variant Tyrosinemia type II [RCV000667629] Chr16:71569853 [GRCh38]
Chr16:71603756 [GRCh37]
Chr16:16q22.2		 likely pathogenic
NM_000353.3(TAT):c.568-2A>G single nucleotide variant Tyrosinemia type II [RCV000667793] Chr16:71572326 [GRCh38]
Chr16:71606229 [GRCh37]
Chr16:16q22.2		 likely pathogenic
NM_000353.3(TAT):c.1224G>A (p.Thr408=) single nucleotide variant Tyrosinemia type II [RCV000665820] Chr16:71568711 [GRCh38]
Chr16:71602614 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.707-1G>A single nucleotide variant Tyrosinemia type II [RCV000664650] Chr16:71571659 [GRCh38]
Chr16:71605562 [GRCh37]
Chr16:16q22.2		 likely pathogenic
NM_000353.3(TAT):c.1297C>T (p.Arg433Trp) single nucleotide variant Tyrosinemia type II [RCV000668575] Chr16:71568212 [GRCh38]
Chr16:71602115 [GRCh37]
Chr16:16q22.2		 pathogenic|likely pathogenic
NM_000353.3(TAT):c.1041+2T>C single nucleotide variant Tyrosinemia type II [RCV000668624] Chr16:71570267 [GRCh38]
Chr16:71604170 [GRCh37]
Chr16:16q22.2		 likely pathogenic
NM_000353.3(TAT):c.1223C>T (p.Thr408Met) single nucleotide variant Tyrosinemia type II [RCV000666556] Chr16:71568712 [GRCh38]
Chr16:71602615 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.1250G>A (p.Arg417Gln) single nucleotide variant Tyrosinemia type II [RCV000664686] Chr16:71568259 [GRCh38]
Chr16:71602162 [GRCh37]
Chr16:16q22.2		 conflicting interpretations of pathogenicity|uncertain significance
NM_000353.3(TAT):c.863_874del (p.Arg288_Trp291del) deletion Tyrosinemia type II [RCV000722007] Chr16:71570717..71570728 [GRCh38]
Chr16:71604620..71604631 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.1042-72G>T single nucleotide variant not provided [RCV001665599] Chr16:71570009 [GRCh38]
Chr16:71603912 [GRCh37]
Chr16:16q22.2		 benign
NM_000353.3(TAT):c.889C>T (p.Arg297Ter) single nucleotide variant Tyrosinemia type II [RCV002500981]|not provided [RCV000760323] Chr16:71570702 [GRCh38]
Chr16:71604605 [GRCh37]
Chr16:16q22.2		 pathogenic|likely pathogenic
NM_000353.3(TAT):c.1242T>C (p.Asn414=) single nucleotide variant Tyrosinemia type II [RCV000967701] Chr16:71568267 [GRCh38]
Chr16:71602170 [GRCh37]
Chr16:16q22.2		 benign
NM_000353.3(TAT):c.804C>T (p.Thr268=) single nucleotide variant TAT-related condition [RCV003943203]|Tyrosinemia type II [RCV000970646] Chr16:71570787 [GRCh38]
Chr16:71604690 [GRCh37]
Chr16:16q22.2		 benign|likely benign
NM_000353.3(TAT):c.687T>C (p.His229=) single nucleotide variant Tyrosinemia type II [RCV001498505] Chr16:71572205 [GRCh38]
Chr16:71606108 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1329T>C (p.His443=) single nucleotide variant Tyrosinemia type II [RCV000979279] Chr16:71568180 [GRCh38]
Chr16:71602083 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.578C>A (p.Ser193Tyr) single nucleotide variant Tyrosinemia type II [RCV000824178] Chr16:71572314 [GRCh38]
Chr16:71606217 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.707-9T>C single nucleotide variant Tyrosinemia type II [RCV001433274] Chr16:71571667 [GRCh38]
Chr16:71605570 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.716G>A (p.Arg239Gln) single nucleotide variant Tyrosinemia type II [RCV000823406] Chr16:71571649 [GRCh38]
Chr16:71605552 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.1115T>C (p.Met372Thr) single nucleotide variant Tyrosinemia type II [RCV001118618] Chr16:71569864 [GRCh38]
Chr16:71603767 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.*742G>A single nucleotide variant Tyrosinemia type II [RCV001120345] Chr16:71567402 [GRCh38]
Chr16:71601305 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.*253G>C single nucleotide variant Tyrosinemia type II [RCV001115456] Chr16:71567891 [GRCh38]
Chr16:71601794 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.*170G>A single nucleotide variant Tyrosinemia type II [RCV001115457] Chr16:71567974 [GRCh38]
Chr16:71601877 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.*163A>C single nucleotide variant Tyrosinemia type II [RCV001115458] Chr16:71567981 [GRCh38]
Chr16:71601884 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.*403G>T single nucleotide variant Tyrosinemia type II [RCV001120350] Chr16:71567741 [GRCh38]
Chr16:71601644 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.1178C>T (p.Thr393Met) single nucleotide variant Tyrosinemia type II [RCV001240156] Chr16:71568757 [GRCh38]
Chr16:71602660 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.1087C>T (p.Leu363Phe) single nucleotide variant Inborn genetic diseases [RCV003273157] Chr16:71569892 [GRCh38]
Chr16:71603795 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.1224+143A>G single nucleotide variant not provided [RCV001654405] Chr16:71568568 [GRCh38]
Chr16:71602471 [GRCh37]
Chr16:16q22.2		 benign
NM_000353.3(TAT):c.1125+270C>T single nucleotide variant not provided [RCV001678738] Chr16:71569584 [GRCh38]
Chr16:71603487 [GRCh37]
Chr16:16q22.2		 benign
NM_000353.3(TAT):c.929T>C (p.Val310Ala) single nucleotide variant TAT-related condition [RCV003948316]|Tyrosinemia type II [RCV000881964] Chr16:71570381 [GRCh38]
Chr16:71604284 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1290G>A (p.Ala430=) single nucleotide variant Tyrosinemia type II [RCV000932959] Chr16:71568219 [GRCh38]
Chr16:71602122 [GRCh37]
Chr16:16q22.2		 likely benign|conflicting interpretations of pathogenicity
NM_000353.3(TAT):c.*660G>C single nucleotide variant Tyrosinemia type II [RCV001120347] Chr16:71567484 [GRCh38]
Chr16:71601387 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.759+5G>A single nucleotide variant Tyrosinemia type II [RCV001248614] Chr16:71571601 [GRCh38]
Chr16:71605504 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.912+113T>C single nucleotide variant not provided [RCV001598060] Chr16:71570566 [GRCh38]
Chr16:71604469 [GRCh37]
Chr16:16q22.2		 benign
NM_000353.3(TAT):c.618T>G (p.Asp206Glu) single nucleotide variant Tyrosinemia type II [RCV001120162] Chr16:71572274 [GRCh38]
Chr16:71606177 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.814del (p.Ile272fs) deletion Tyrosinemia type II [RCV001043576] Chr16:71570777 [GRCh38]
Chr16:71604680 [GRCh37]
Chr16:16q22.2		 pathogenic|likely pathogenic
NM_000353.3(TAT):c.710C>T (p.Ala237Val) single nucleotide variant Tyrosinemia type II [RCV001120161] Chr16:71571655 [GRCh38]
Chr16:71605558 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.*479T>A single nucleotide variant Tyrosinemia type II [RCV001120348] Chr16:71567665 [GRCh38]
Chr16:71601568 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.*409G>A single nucleotide variant Tyrosinemia type II [RCV001120349] Chr16:71567735 [GRCh38]
Chr16:71601638 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.1146T>C (p.His382=) single nucleotide variant Tyrosinemia type II [RCV001118617] Chr16:71568789 [GRCh38]
Chr16:71602692 [GRCh37]
Chr16:16q22.2		 conflicting interpretations of pathogenicity|uncertain significance
NM_000353.3(TAT):c.*110C>T single nucleotide variant Tyrosinemia type II [RCV001115459]|not provided [RCV002290603] Chr16:71568034 [GRCh38]
Chr16:71601937 [GRCh37]
Chr16:16q22.2		 benign|likely benign
NM_000353.3(TAT):c.1217C>T (p.Pro406Leu) single nucleotide variant Tyrosinemia type II [RCV001255958] Chr16:71568718 [GRCh38]
Chr16:71602621 [GRCh37]
Chr16:16q22.2		 pathogenic
NM_000353.3(TAT):c.623A>T (p.Lys208Met) single nucleotide variant Tyrosinemia type II [RCV001331167] Chr16:71572269 [GRCh38]
Chr16:71606172 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.1269C>T (p.Pro423=) single nucleotide variant Tyrosinemia type II [RCV001422140] Chr16:71568240 [GRCh38]
Chr16:71602143 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1239G>A (p.Pro413=) single nucleotide variant Tyrosinemia type II [RCV001414997] Chr16:71568270 [GRCh38]
Chr16:71602173 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.669A>C (p.Ser223=) single nucleotide variant Tyrosinemia type II [RCV001423131] Chr16:71572223 [GRCh38]
Chr16:71606126 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1236C>T (p.Tyr412=) single nucleotide variant Tyrosinemia type II [RCV001392292] Chr16:71568273 [GRCh38]
Chr16:71602176 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.890G>A (p.Arg297Gln) single nucleotide variant Tyrosinemia type II [RCV001300016] Chr16:71570701 [GRCh38]
Chr16:71604604 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.1155A>G (p.Glu385=) single nucleotide variant Tyrosinemia type II [RCV001413191] Chr16:71568780 [GRCh38]
Chr16:71602683 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.683G>C (p.Arg228Pro) single nucleotide variant Tyrosinemia type II [RCV001365810] Chr16:71572209 [GRCh38]
Chr16:71606112 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.1224+9_1224+10del deletion Tyrosinemia type II [RCV001438712] Chr16:71568701..71568702 [GRCh38]
Chr16:71602604..71602605 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.795C>T (p.Thr265=) single nucleotide variant Tyrosinemia type II [RCV001481686] Chr16:71570796 [GRCh38]
Chr16:71604699 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1017C>T (p.Tyr339=) single nucleotide variant Tyrosinemia type II [RCV001404953] Chr16:71570293 [GRCh38]
Chr16:71604196 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1126-10G>A single nucleotide variant Tyrosinemia type II [RCV001487781] Chr16:71568819 [GRCh38]
Chr16:71602722 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1042-9T>G single nucleotide variant Tyrosinemia type II [RCV001475318] Chr16:71569946 [GRCh38]
Chr16:71603849 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.594G>T (p.Leu198=) single nucleotide variant Tyrosinemia type II [RCV001400016] Chr16:71572298 [GRCh38]
Chr16:71606201 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1299G>C (p.Arg433=) single nucleotide variant Tyrosinemia type II [RCV001480202] Chr16:71568210 [GRCh38]
Chr16:71602113 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1069T>C (p.Leu357=) single nucleotide variant Tyrosinemia type II [RCV001439295] Chr16:71569910 [GRCh38]
Chr16:71603813 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1164C>T (p.Asn388=) single nucleotide variant Tyrosinemia type II [RCV001475624] Chr16:71568771 [GRCh38]
Chr16:71602674 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.663T>C (p.Cys221=) single nucleotide variant Tyrosinemia type II [RCV001462335] Chr16:71572229 [GRCh38]
Chr16:71606132 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1209C>T (p.His403=) single nucleotide variant Tyrosinemia type II [RCV001503373] Chr16:71568726 [GRCh38]
Chr16:71602629 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1179G>A (p.Thr393=) single nucleotide variant Tyrosinemia type II [RCV001504286] Chr16:71568756 [GRCh38]
Chr16:71602659 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1125+8T>C single nucleotide variant Tyrosinemia type II [RCV001401503] Chr16:71569846 [GRCh38]
Chr16:71603749 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1008A>G (p.Gly336=) single nucleotide variant Tyrosinemia type II [RCV001493591] Chr16:71570302 [GRCh38]
Chr16:71604205 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.760-8C>G single nucleotide variant Tyrosinemia type II [RCV001434997] Chr16:71570839 [GRCh38]
Chr16:71604742 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1203T>G (p.Ser401=) single nucleotide variant Tyrosinemia type II [RCV001429919] Chr16:71568732 [GRCh38]
Chr16:71602635 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.840G>A (p.Lys280=) single nucleotide variant Tyrosinemia type II [RCV001446330] Chr16:71570751 [GRCh38]
Chr16:71604654 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.759+8T>A single nucleotide variant Tyrosinemia type II [RCV001428973] Chr16:71571598 [GRCh38]
Chr16:71605501 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1068G>T (p.Ala356=) single nucleotide variant Tyrosinemia type II [RCV001419019] Chr16:71569911 [GRCh38]
Chr16:71603814 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.921T>C (p.Asp307=) single nucleotide variant Tyrosinemia type II [RCV001476447] Chr16:71570389 [GRCh38]
Chr16:71604292 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1042-5del deletion Tyrosinemia type II [RCV001470306] Chr16:71569942 [GRCh38]
Chr16:71603845 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1050T>C (p.Ala350=) single nucleotide variant Tyrosinemia type II [RCV001460707] Chr16:71569929 [GRCh38]
Chr16:71603832 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.885T>C (p.His295=) single nucleotide variant Tyrosinemia type II [RCV001471329] Chr16:71570706 [GRCh38]
Chr16:71604609 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1263A>C (p.Thr421=) single nucleotide variant Tyrosinemia type II [RCV001505065] Chr16:71568246 [GRCh38]
Chr16:71602149 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.660C>T (p.Pro220=) single nucleotide variant Tyrosinemia type II [RCV001502011] Chr16:71572232 [GRCh38]
Chr16:71606135 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.592C>T (p.Leu198=) single nucleotide variant Tyrosinemia type II [RCV001419371] Chr16:71572300 [GRCh38]
Chr16:71606203 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1152A>G (p.Pro384=) single nucleotide variant Tyrosinemia type II [RCV001490200] Chr16:71568783 [GRCh38]
Chr16:71602686 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1041+10G>A single nucleotide variant Tyrosinemia type II [RCV001437839] Chr16:71570259 [GRCh38]
Chr16:71604162 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1098C>T (p.Val366=) single nucleotide variant Tyrosinemia type II [RCV001401581] Chr16:71569881 [GRCh38]
Chr16:71603784 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1113T>G (p.Ala371=) single nucleotide variant Tyrosinemia type II [RCV001483101] Chr16:71569866 [GRCh38]
Chr16:71603769 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.870C>G (p.Gly290=) single nucleotide variant Tyrosinemia type II [RCV001425380] Chr16:71570721 [GRCh38]
Chr16:71604624 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.714A>T (p.Ala238=) single nucleotide variant Tyrosinemia type II [RCV001416034] Chr16:71571651 [GRCh38]
Chr16:71605554 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1152A>C (p.Pro384=) single nucleotide variant Tyrosinemia type II [RCV001402058] Chr16:71568783 [GRCh38]
Chr16:71602686 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.942G>A (p.Gln314=) single nucleotide variant Tyrosinemia type II [RCV001418441] Chr16:71570368 [GRCh38]
Chr16:71604271 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1131A>C (p.Gly377=) single nucleotide variant Tyrosinemia type II [RCV001489313] Chr16:71568804 [GRCh38]
Chr16:71602707 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.912+1G>A single nucleotide variant Tyrosinemia type II [RCV002238565] Chr16:71570678 [GRCh38]
Chr16:71604581 [GRCh37]
Chr16:16q22.2		 likely pathogenic
NM_000353.3(TAT):c.858C>A (p.Gly286=) single nucleotide variant Tyrosinemia type II [RCV002074015]|not provided [RCV001761381] Chr16:71570733 [GRCh38]
Chr16:71604636 [GRCh37]
Chr16:16q22.2		 likely benign|uncertain significance
NM_000353.3(TAT):c.966del (p.Ile322fs) deletion Tyrosinemia type II [RCV001950359] Chr16:71570344 [GRCh38]
Chr16:71604247 [GRCh37]
Chr16:16q22.2		 pathogenic
NM_000353.3(TAT):c.582G>A (p.Trp194Ter) single nucleotide variant Tyrosinemia type II [RCV002039621] Chr16:71572310 [GRCh38]
Chr16:71606213 [GRCh37]
Chr16:16q22.2		 pathogenic
NM_000353.3(TAT):c.825del (p.Cys275fs) deletion Tyrosinemia type II [RCV001941843] Chr16:71570766 [GRCh38]
Chr16:71604669 [GRCh37]
Chr16:16q22.2		 pathogenic|likely pathogenic
NM_000353.3(TAT):c.932A>G (p.Lys311Arg) single nucleotide variant Tyrosinemia type II [RCV001943451] Chr16:71570378 [GRCh38]
Chr16:71604281 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.707-2A>G single nucleotide variant Tyrosinemia type II [RCV001973516] Chr16:71571660 [GRCh38]
Chr16:71605563 [GRCh37]
Chr16:16q22.2		 pathogenic|likely pathogenic
NM_000353.3(TAT):c.759+1G>A single nucleotide variant Tyrosinemia type II [RCV002015283] Chr16:71571605 [GRCh38]
Chr16:71605508 [GRCh37]
Chr16:16q22.2		 likely pathogenic
NM_000353.3(TAT):c.1281G>A (p.Met427Ile) single nucleotide variant Tyrosinemia type II [RCV002010418] Chr16:71568228 [GRCh38]
Chr16:71602131 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.916C>T (p.Arg306Ter) single nucleotide variant Tyrosinemia type II [RCV001924420] Chr16:71570394 [GRCh38]
Chr16:71604297 [GRCh37]
Chr16:16q22.2		 pathogenic|likely pathogenic
NM_000353.3(TAT):c.1125+9G>A single nucleotide variant Tyrosinemia type II [RCV002075932] Chr16:71569845 [GRCh38]
Chr16:71603748 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.594G>C (p.Leu198=) single nucleotide variant Tyrosinemia type II [RCV002130417] Chr16:71572298 [GRCh38]
Chr16:71606201 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.606A>G (p.Glu202=) single nucleotide variant Tyrosinemia type II [RCV002188949] Chr16:71572286 [GRCh38]
Chr16:71606189 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.760-12G>A single nucleotide variant Tyrosinemia type II [RCV002084780] Chr16:71570843 [GRCh38]
Chr16:71604746 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.933G>A (p.Lys311=) single nucleotide variant Tyrosinemia type II [RCV002106111] Chr16:71570377 [GRCh38]
Chr16:71604280 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1126-6G>T single nucleotide variant Tyrosinemia type II [RCV002187305] Chr16:71568815 [GRCh38]
Chr16:71602718 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.706+10G>A single nucleotide variant Tyrosinemia type II [RCV002209463] Chr16:71572176 [GRCh38]
Chr16:71606079 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.738T>C (p.Ala246=) single nucleotide variant Tyrosinemia type II [RCV002169819] Chr16:71571627 [GRCh38]
Chr16:71605530 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.726C>T (p.Val242=) single nucleotide variant Tyrosinemia type II [RCV002208040] Chr16:71571639 [GRCh38]
Chr16:71605542 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.568-9T>C single nucleotide variant Tyrosinemia type II [RCV002088259] Chr16:71572333 [GRCh38]
Chr16:71606236 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1206C>T (p.Val402=) single nucleotide variant Tyrosinemia type II [RCV002093716] Chr16:71568729 [GRCh38]
Chr16:71602632 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1119C>T (p.Tyr373=) single nucleotide variant Tyrosinemia type II [RCV002109900] Chr16:71569860 [GRCh38]
Chr16:71603763 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1248C>T (p.Ile416=) single nucleotide variant Tyrosinemia type II [RCV002213867] Chr16:71568261 [GRCh38]
Chr16:71602164 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.715C>A (p.Arg239=) single nucleotide variant Tyrosinemia type II [RCV002172399] Chr16:71571650 [GRCh38]
Chr16:71605553 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1062T>C (p.Tyr354=) single nucleotide variant Tyrosinemia type II [RCV002171685] Chr16:71569917 [GRCh38]
Chr16:71603820 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1225-5T>C single nucleotide variant Tyrosinemia type II [RCV002213768] Chr16:71568289 [GRCh38]
Chr16:71602192 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.807T>C (p.Asp269=) single nucleotide variant Tyrosinemia type II [RCV002071264] Chr16:71570784 [GRCh38]
Chr16:71604687 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1125+10T>C single nucleotide variant Tyrosinemia type II [RCV002211863] Chr16:71569844 [GRCh38]
Chr16:71603747 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1042-10C>T single nucleotide variant Tyrosinemia type II [RCV002213522] Chr16:71569947 [GRCh38]
Chr16:71603850 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.603G>A (p.Leu201=) single nucleotide variant Tyrosinemia type II [RCV002078381] Chr16:71572289 [GRCh38]
Chr16:71606192 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1065G>A (p.Gly355=) single nucleotide variant Tyrosinemia type II [RCV002180765] Chr16:71569914 [GRCh38]
Chr16:71603817 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1233G>A (p.Glu411=) single nucleotide variant Tyrosinemia type II [RCV002177294] Chr16:71568276 [GRCh38]
Chr16:71602179 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1126-14T>C single nucleotide variant Tyrosinemia type II [RCV002160593] Chr16:71568823 [GRCh38]
Chr16:71602726 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.597A>G (p.Lys199=) single nucleotide variant Tyrosinemia type II [RCV002162539] Chr16:71572295 [GRCh38]
Chr16:71606198 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1170G>T (p.Val390=) single nucleotide variant Tyrosinemia type II [RCV002176975] Chr16:71568765 [GRCh38]
Chr16:71602668 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.759+7C>T single nucleotide variant Tyrosinemia type II [RCV002154681] Chr16:71571599 [GRCh38]
Chr16:71605502 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.945C>T (p.Arg315=) single nucleotide variant Tyrosinemia type II [RCV002183021] Chr16:71570365 [GRCh38]
Chr16:71604268 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.813C>T (p.Pro271=) single nucleotide variant Tyrosinemia type II [RCV002200507] Chr16:71570778 [GRCh38]
Chr16:71604681 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.648T>C (p.Asn216=) single nucleotide variant Tyrosinemia type II [RCV002139977] Chr16:71572244 [GRCh38]
Chr16:71606147 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.707-14T>C single nucleotide variant Tyrosinemia type II [RCV002160532] Chr16:71571672 [GRCh38]
Chr16:71605575 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1293C>T (p.Cys431=) single nucleotide variant Tyrosinemia type II [RCV002180191] Chr16:71568216 [GRCh38]
Chr16:71602119 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.759+8T>G single nucleotide variant Tyrosinemia type II [RCV002157666] Chr16:71571598 [GRCh38]
Chr16:71605501 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.570A>G (p.Pro190=) single nucleotide variant Tyrosinemia type II [RCV002178979] Chr16:71572322 [GRCh38]
Chr16:71606225 [GRCh37]
Chr16:16q22.2		 likely benign
Single allele duplication not specified [RCV002286378] Chr16:71219688..71768356 [GRCh38]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.632_634delinsA (p.Cys211fs) indel Tyrosinemia type II [RCV002309646] Chr16:71572258..71572260 [GRCh38]
Chr16:71606161..71606163 [GRCh37]
Chr16:16q22.2		 likely pathogenic
NM_000353.3(TAT):c.974G>T (p.Gly325Val) single nucleotide variant Tyrosinemia type II [RCV002296000] Chr16:71570336 [GRCh38]
Chr16:71604239 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.1015del (p.Tyr339fs) deletion Tyrosinemia type II [RCV002306683] Chr16:71570295 [GRCh38]
Chr16:71604198 [GRCh37]
Chr16:16q22.2		 likely pathogenic
NM_000353.3(TAT):c.1037_1038del (p.Leu346fs) deletion Tyrosinemia type II [RCV002307921] Chr16:71570272..71570273 [GRCh38]
Chr16:71604175..71604176 [GRCh37]
Chr16:16q22.2		 likely pathogenic
NM_000353.3(TAT):c.680_692del (p.Lys227fs) deletion Tyrosinemia type II [RCV002306864] Chr16:71572200..71572212 [GRCh38]
Chr16:71606103..71606115 [GRCh37]
Chr16:16q22.2		 likely pathogenic
NM_000353.3(TAT):c.769G>A (p.Asp257Asn) single nucleotide variant Tyrosinemia type II [RCV002908903] Chr16:71570822 [GRCh38]
Chr16:71604725 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.756C>T (p.Asp252=) single nucleotide variant Tyrosinemia type II [RCV003073807] Chr16:71571609 [GRCh38]
Chr16:71605512 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1100G>A (p.Arg367His) single nucleotide variant Tyrosinemia type II [RCV003095776] Chr16:71569879 [GRCh38]
Chr16:71603782 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.997C>T (p.Arg333Cys) single nucleotide variant Inborn genetic diseases [RCV003250713]|Tyrosinemia type II [RCV003076276] Chr16:71570313 [GRCh38]
Chr16:71604216 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.1042-12del deletion Tyrosinemia type II [RCV002638512] Chr16:71569949 [GRCh38]
Chr16:71603852 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.944G>A (p.Arg315His) single nucleotide variant Inborn genetic diseases [RCV003161690]|Tyrosinemia type II [RCV003078984] Chr16:71570366 [GRCh38]
Chr16:71604269 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.1125+4A>G single nucleotide variant Tyrosinemia type II [RCV003079571] Chr16:71569850 [GRCh38]
Chr16:71603753 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.723T>C (p.Cys241=) single nucleotide variant Tyrosinemia type II [RCV003079645] Chr16:71571642 [GRCh38]
Chr16:71605545 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1098C>G (p.Val366=) single nucleotide variant Tyrosinemia type II [RCV002760739] Chr16:71569881 [GRCh38]
Chr16:71603784 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1188A>C (p.Leu396Phe) single nucleotide variant Inborn genetic diseases [RCV002799885] Chr16:71568747 [GRCh38]
Chr16:71602650 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.979C>T (p.Leu327=) single nucleotide variant Tyrosinemia type II [RCV003017976] Chr16:71570331 [GRCh38]
Chr16:71604234 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1225-10C>G single nucleotide variant Tyrosinemia type II [RCV002659428] Chr16:71568294 [GRCh38]
Chr16:71602197 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1266C>T (p.Val422=) single nucleotide variant Tyrosinemia type II [RCV003057341] Chr16:71568243 [GRCh38]
Chr16:71602146 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1125+1del deletion Tyrosinemia type II [RCV003040362] Chr16:71569853 [GRCh38]
Chr16:71603756 [GRCh37]
Chr16:16q22.2		 pathogenic
NM_000353.3(TAT):c.759+10G>A single nucleotide variant Tyrosinemia type II [RCV003005935] Chr16:71571596 [GRCh38]
Chr16:71605499 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1038C>G (p.Leu346=) single nucleotide variant Tyrosinemia type II [RCV002766896] Chr16:71570272 [GRCh38]
Chr16:71604175 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1125+11G>A single nucleotide variant Tyrosinemia type II [RCV002917313] Chr16:71569843 [GRCh38]
Chr16:71603746 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.760-7T>C single nucleotide variant Tyrosinemia type II [RCV002766328] Chr16:71570838 [GRCh38]
Chr16:71604741 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.943C>T (p.Arg315Cys) single nucleotide variant Tyrosinemia type II [RCV002597807] Chr16:71570367 [GRCh38]
Chr16:71604270 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.949T>C (p.Leu317=) single nucleotide variant Tyrosinemia type II [RCV002988595] Chr16:71570361 [GRCh38]
Chr16:71604264 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1224+8C>T single nucleotide variant Tyrosinemia type II [RCV002810734] Chr16:71568703 [GRCh38]
Chr16:71602606 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1139T>C (p.Met380Thr) single nucleotide variant Tyrosinemia type II [RCV003062653] Chr16:71568796 [GRCh38]
Chr16:71602699 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.993A>G (p.Leu331=) single nucleotide variant Tyrosinemia type II [RCV002580738] Chr16:71570317 [GRCh38]
Chr16:71604220 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.993A>T (p.Leu331=) single nucleotide variant Tyrosinemia type II [RCV003028547] Chr16:71570317 [GRCh38]
Chr16:71604220 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1332T>C (p.Cys444=) single nucleotide variant Tyrosinemia type II [RCV003086742] Chr16:71568177 [GRCh38]
Chr16:71602080 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1364A>T (p.Ter455Leu) single nucleotide variant Tyrosinemia type II [RCV002943146] Chr16:71568145 [GRCh38]
Chr16:71602048 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.960T>C (p.Cys320=) single nucleotide variant Tyrosinemia type II [RCV002654371] Chr16:71570350 [GRCh38]
Chr16:71604253 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.805G>A (p.Asp269Asn) single nucleotide variant Tyrosinemia type II [RCV003140876] Chr16:71570786 [GRCh38]
Chr16:71604689 [GRCh37]
Chr16:16q22.2		 uncertain significance
NM_000353.3(TAT):c.1028_1029del (p.Leu343fs) deletion Tyrosinemia type II [RCV003464662] Chr16:71570281..71570282 [GRCh38]
Chr16:71604184..71604185 [GRCh37]
Chr16:16q22.2		 likely pathogenic
NM_000353.3(TAT):c.706+2T>C single nucleotide variant Tyrosinemia type II [RCV003464663] Chr16:71572184 [GRCh38]
Chr16:71606087 [GRCh37]
Chr16:16q22.2		 likely pathogenic
NM_000353.3(TAT):c.760-11C>T single nucleotide variant Tyrosinemia type II [RCV003873067] Chr16:71570842 [GRCh38]
Chr16:71604745 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.599_603del (p.Gln200fs) deletion Tyrosinemia type II [RCV003466430] Chr16:71572289..71572293 [GRCh38]
Chr16:71606192..71606196 [GRCh37]
Chr16:16q22.2		 likely pathogenic
NM_000353.3(TAT):c.1224G>T (p.Thr408=) single nucleotide variant Tyrosinemia type II [RCV003464661] Chr16:71568711 [GRCh38]
Chr16:71602614 [GRCh37]
Chr16:16q22.2		 pathogenic|likely pathogenic
NM_000353.3(TAT):c.864G>A (p.Arg288=) single nucleotide variant Tyrosinemia type II [RCV003598945] Chr16:71570727 [GRCh38]
Chr16:71604630 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1041+2T>G single nucleotide variant Tyrosinemia type II [RCV003495726] Chr16:71570267 [GRCh38]
Chr16:71604170 [GRCh37]
Chr16:16q22.2		 likely pathogenic
NM_000353.3(TAT):c.601C>T (p.Leu201=) single nucleotide variant Tyrosinemia type II [RCV003495948] Chr16:71572291 [GRCh38]
Chr16:71606194 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.882T>C (p.Ile294=) single nucleotide variant Tyrosinemia type II [RCV003494655] Chr16:71570709 [GRCh38]
Chr16:71604612 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1041+17C>T single nucleotide variant Tyrosinemia type II [RCV003597936] Chr16:71570252 [GRCh38]
Chr16:71604155 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1020C>T (p.His340=) single nucleotide variant Tyrosinemia type II [RCV003597923] Chr16:71570290 [GRCh38]
Chr16:71604193 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.913-15G>C single nucleotide variant Tyrosinemia type II [RCV003598430] Chr16:71570412 [GRCh38]
Chr16:71604315 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.849G>A (p.Leu283=) single nucleotide variant Tyrosinemia type II [RCV003598388] Chr16:71570742 [GRCh38]
Chr16:71604645 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1125+10T>A single nucleotide variant Tyrosinemia type II [RCV003496655] Chr16:71569844 [GRCh38]
Chr16:71603747 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1221A>G (p.Ala407=) single nucleotide variant Tyrosinemia type II [RCV003599839] Chr16:71568714 [GRCh38]
Chr16:71602617 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.912+20G>C single nucleotide variant Tyrosinemia type II [RCV003597842] Chr16:71570659 [GRCh38]
Chr16:71604562 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1047T>C (p.Asn349=) single nucleotide variant Tyrosinemia type II [RCV003598827] Chr16:71569932 [GRCh38]
Chr16:71603835 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1126-17C>T single nucleotide variant Tyrosinemia type II [RCV003494813] Chr16:71568826 [GRCh38]
Chr16:71602729 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.568-17C>T single nucleotide variant Tyrosinemia type II [RCV003494863] Chr16:71572341 [GRCh38]
Chr16:71606244 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.810C>A (p.Val270=) single nucleotide variant Tyrosinemia type II [RCV003598254] Chr16:71570781 [GRCh38]
Chr16:71604684 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1002C>T (p.Thr334=) single nucleotide variant Tyrosinemia type II [RCV003599846] Chr16:71570308 [GRCh38]
Chr16:71604211 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1122C>T (p.Leu374=) single nucleotide variant Tyrosinemia type II [RCV003495740] Chr16:71569857 [GRCh38]
Chr16:71603760 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.759+17A>T single nucleotide variant Tyrosinemia type II [RCV003496492] Chr16:71571589 [GRCh38]
Chr16:71605492 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1042-15T>C single nucleotide variant Tyrosinemia type II [RCV003597623] Chr16:71569952 [GRCh38]
Chr16:71603855 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.849G>T (p.Leu283=) single nucleotide variant Tyrosinemia type II [RCV003597637] Chr16:71570742 [GRCh38]
Chr16:71604645 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1282C>T (p.Leu428=) single nucleotide variant Tyrosinemia type II [RCV003597880] Chr16:71568227 [GRCh38]
Chr16:71602130 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1041+19C>G single nucleotide variant Tyrosinemia type II [RCV003599326] Chr16:71570250 [GRCh38]
Chr16:71604153 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1225-15C>T single nucleotide variant Tyrosinemia type II [RCV003495570] Chr16:71568299 [GRCh38]
Chr16:71602202 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1225-12T>C single nucleotide variant Tyrosinemia type II [RCV003496637] Chr16:71568296 [GRCh38]
Chr16:71602199 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.759+19A>G single nucleotide variant Tyrosinemia type II [RCV003495429] Chr16:71571587 [GRCh38]
Chr16:71605490 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1098C>A (p.Val366=) single nucleotide variant Tyrosinemia type II [RCV003495972] Chr16:71569881 [GRCh38]
Chr16:71603784 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.912+12_912+13insGGG insertion Tyrosinemia type II [RCV003496070] Chr16:71570666..71570667 [GRCh38]
Chr16:71604569..71604570 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.760-14G>A single nucleotide variant Tyrosinemia type II [RCV003879464] Chr16:71570845 [GRCh38]
Chr16:71604748 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.760-14G>C single nucleotide variant Tyrosinemia type II [RCV003496757] Chr16:71570845 [GRCh38]
Chr16:71604748 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1125+16G>A single nucleotide variant Tyrosinemia type II [RCV003494791] Chr16:71569838 [GRCh38]
Chr16:71603741 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.912+16A>C single nucleotide variant Tyrosinemia type II [RCV003598477] Chr16:71570663 [GRCh38]
Chr16:71604566 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1126-8T>C single nucleotide variant Tyrosinemia type II [RCV003495680] Chr16:71568817 [GRCh38]
Chr16:71602720 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1041+13C>T single nucleotide variant Tyrosinemia type II [RCV003598508] Chr16:71570256 [GRCh38]
Chr16:71604159 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.915C>A (p.Ile305=) single nucleotide variant Tyrosinemia type II [RCV003599625] Chr16:71570395 [GRCh38]
Chr16:71604298 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.810C>T (p.Val270=) single nucleotide variant Tyrosinemia type II [RCV003599646] Chr16:71570781 [GRCh38]
Chr16:71604684 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1311C>T (p.Phe437=) single nucleotide variant Tyrosinemia type II [RCV003495935] Chr16:71568198 [GRCh38]
Chr16:71602101 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1224+11G>T single nucleotide variant Tyrosinemia type II [RCV003599416] Chr16:71568700 [GRCh38]
Chr16:71602603 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.568-7T>C single nucleotide variant Tyrosinemia type II [RCV003496009] Chr16:71572331 [GRCh38]
Chr16:71606234 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1042-16T>C single nucleotide variant Tyrosinemia type II [RCV003496041] Chr16:71569953 [GRCh38]
Chr16:71603856 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.669A>G (p.Ser223=) single nucleotide variant Tyrosinemia type II [RCV003496164] Chr16:71572223 [GRCh38]
Chr16:71606126 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.742G>T (p.Glu248Ter) single nucleotide variant Tyrosinemia type II [RCV003496182] Chr16:71571623 [GRCh38]
Chr16:71605526 [GRCh37]
Chr16:16q22.2		 pathogenic
NM_000353.3(TAT):c.1185G>A (p.Arg395=) single nucleotide variant Tyrosinemia type II [RCV003824539] Chr16:71568750 [GRCh38]
Chr16:71602653 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1042-2_1042del deletion Tyrosinemia type II [RCV003597461] Chr16:71569937..71569939 [GRCh38]
Chr16:71603840..71603842 [GRCh37]
Chr16:16q22.2		 likely pathogenic
NM_000353.3(TAT):c.706+7C>T single nucleotide variant Tyrosinemia type II [RCV003599012] Chr16:71572179 [GRCh38]
Chr16:71606082 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.825T>A (p.Cys275Ter) single nucleotide variant Tyrosinemia type II [RCV003494973] Chr16:71570766 [GRCh38]
Chr16:71604669 [GRCh37]
Chr16:16q22.2		 pathogenic
NM_000353.3(TAT):c.783A>G (p.Glu261=) single nucleotide variant Tyrosinemia type II [RCV003599027] Chr16:71570808 [GRCh38]
Chr16:71604711 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.648del (p.Pro217fs) deletion Tyrosinemia type II [RCV003598532] Chr16:71572244 [GRCh38]
Chr16:71606147 [GRCh37]
Chr16:16q22.2		 pathogenic
NM_000353.3(TAT):c.707-15A>G single nucleotide variant Tyrosinemia type II [RCV003598551] Chr16:71571673 [GRCh38]
Chr16:71605576 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1042-6T>G single nucleotide variant Tyrosinemia type II [RCV003598616] Chr16:71569943 [GRCh38]
Chr16:71603846 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1245C>T (p.Phe415=) single nucleotide variant Tyrosinemia type II [RCV003599141] Chr16:71568264 [GRCh38]
Chr16:71602167 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1125+15G>A single nucleotide variant Tyrosinemia type II [RCV003878932] Chr16:71569839 [GRCh38]
Chr16:71603742 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1188_1191del (p.Val397fs) deletion Tyrosinemia type II [RCV003496407] Chr16:71568744..71568747 [GRCh38]
Chr16:71602647..71602650 [GRCh37]
Chr16:16q22.2		 pathogenic
NM_000353.3(TAT):c.707-9T>A single nucleotide variant Tyrosinemia type II [RCV003811080] Chr16:71571667 [GRCh38]
Chr16:71605570 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.759+13C>T single nucleotide variant Tyrosinemia type II [RCV003834956] Chr16:71571593 [GRCh38]
Chr16:71605496 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1126-15C>T single nucleotide variant Tyrosinemia type II [RCV003497192] Chr16:71568824 [GRCh38]
Chr16:71602727 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1041+19C>T single nucleotide variant Tyrosinemia type II [RCV003852504] Chr16:71570250 [GRCh38]
Chr16:71604153 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.913-11del deletion Tyrosinemia type II [RCV003836241] Chr16:71570408 [GRCh38]
Chr16:71604311 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1143A>G (p.Glu381=) single nucleotide variant Tyrosinemia type II [RCV003834547] Chr16:71568792 [GRCh38]
Chr16:71602695 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.912+12G>T single nucleotide variant Tyrosinemia type II [RCV003864428] Chr16:71570667 [GRCh38]
Chr16:71604570 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.913-15G>A single nucleotide variant Tyrosinemia type II [RCV003865397] Chr16:71570412 [GRCh38]
Chr16:71604315 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1125+15_1125+17del deletion Tyrosinemia type II [RCV003871452] Chr16:71569837..71569839 [GRCh38]
Chr16:71603740..71603742 [GRCh37]
Chr16:16q22.2		 likely benign
NM_000353.3(TAT):c.1041+14C>T single nucleotide variant Tyrosinemia type II [RCV003871832] Chr16:71570255 [GRCh38]
Chr16:71604158 [GRCh37]
Chr16:16q22.2		 likely benign
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:83
Count of miRNA genes:81
Interacting mature miRNAs:83
Transcripts:ENST00000561529
Prediction methods:Miranda, Rnahybrid
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


Expression


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system sensory system adipose tissue appendage entire extraembryonic component
High
Medium 123 123 123 330 2
Low 173 15 491 288 353 241 389 16 255 28 179 341 50 430 42 1
Below cutoff 886 652 799 173 718 84 1358 353 1917 251 440 862 95 564 735 1

Sequence


Reference Sequences
RefSeq Acc Id: ENST00000561529
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl1671,565,789 - 71,578,187 (+)Ensembl
RefSeq Acc Id: ENST00000656895
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl1671,564,952 - 71,572,439 (+)Ensembl
RefSeq Acc Id: ENST00000666821
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl1671,564,970 - 71,572,426 (+)Ensembl
RefSeq Acc Id: ENST00000670228
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl1671,565,017 - 71,572,437 (+)Ensembl
RefSeq Acc Id: NR_103851
RefSeq Status: VALIDATED
Type: NON-CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh381671,565,789 - 71,572,438 (+)NCBI
HuRef1657,366,901 - 57,374,322 (+)NCBI
CHM1_11673,012,514 - 73,019,163 (+)NCBI
T2T-CHM13v2.01677,382,983 - 77,389,631 (+)NCBI
Sequence:
RefSeq Acc Id: NR_103852
RefSeq Status: VALIDATED
Type: NON-CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh381671,565,016 - 71,572,438 (+)NCBI
HuRef1657,366,901 - 57,374,322 (+)NCBI
CHM1_11673,011,741 - 73,019,163 (+)NCBI
T2T-CHM13v2.01677,382,208 - 77,389,631 (+)NCBI
Sequence:

Additional Information

Database Acc Id Source(s)
COSMIC TAT-AS1 COSMIC
Ensembl Genes ENSG00000260886 Ensembl, ENTREZGENE
Ensembl Transcript ENST00000561529 ENTREZGENE
  ENST00000656895 ENTREZGENE
GTEx ENSG00000260886 GTEx
HGNC ID HGNC:51369 ENTREZGENE
Human Proteome Map TAT-AS1 Human Proteome Map
NCBI Gene TAT-AS1 ENTREZGENE
RNAcentral URS000075B8BC RNACentral
  URS000075C408 RNACentral